1. Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells. Issue 9 (6th August 2019) Authors: Avvakumova, S.; Pandolfi, L.; Soprano, E.; Moretto, L.; Bellini, M.; Galbiati, E.; Rizzuto, M. A.; Colombo, M.; Allevi, R.; Corsi, F.; Sánchez Iglesias, A.; Prosperi, D. Journal: Nanoscale advances Issue: Volume 1:Issue 9(2019) Page Start: 3626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗